Global liver cancer diagnostics market
As the importance of early detection and early treatment of liver cancer increases, the global market for liver cancer diagnostic drugs shows promising growth.
The global liver cancer diagnostics market is experiencing significant growth as attention to the early detection and treatment of liver cancer (hepatocellular carcinoma) increases. Liver cancer is a leading cause of cancer-related deaths worldwide. Proper and accurate diagnosis plays a crucial role in improving patient outcomes and survival rates. According to the latest market report, the market revenue for liver cancer diagnostics reached $2.1 billion in 2021 and is expected to grow steadily at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2022 to 2030, reaching $4.6 billion by 2030. The rising incidence of liver cancer is driven by factors such as hepatitis B and C infections, alcohol-related liver disease, and non-alcoholic fatty liver disease (NAFLD), which are fueling the demand for effective diagnostic tools. Liver cancer diagnostics include imaging technologies such as ultrasound, CT (computed tomography), MRI (magnetic resonance imaging), and PET (positron emission tomography), as well as blood tests and biopsies, which are used to accurately identify the presence and stage of liver cancer. For application methods, please check the [PDF download] button or apply directly through the related links.
- Company：Panorama Data Insights Ltd.
- Price：Other
